Thermo Fisher Scientific has announced that the company is to acquire Dionex for approximately $2.1 billion.
Thermo Fisher Scientific has announced that the company is to acquire Dionex for approximately $2.1 billion.
"We believe the combination of Thermo Fisher and Dionex is extremely compelling from a technology, market and financial perspective," said Marc N. Casper, president and chief executive officer of Thermo Fisher in a statement. "Dionex's strength in chromatography instruments, software and consumables complements our leading positions in mass spectrometry and laboratory information management systems.”
According to the companies this transaction will allow them to bring together their complementary chromatography portfolios to create one of the most extensive chromatography instruments, software and consumables offerings in the industry. Specifically, it will combine Dionex's ion and liquid chromatography systems and consumables with Thermo Fisher's gas chromatography systems and consumables. It will also allow Dionex's gold standard chromatography data system to be coupled with Thermo Fisher's enterprise laboratory information management systems to create what they claim will be the most comprehensive desktop and enterprise software capabilities in the industry.
Thermo is also expecting to benefit from Dionex's significant customer base and relationships in attractive applied markets, including environmental analysis, food safety and other industrial sectors.
The transaction is expected to be completed in the first quarter of 2011.
For more information visit www.thermoscientific.com
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.